Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interventions for treating tuberculous pericarditis.

B M Mayosi1, J A Volmink, P J Commerford

  • 1Department of Cardiovascular Medicine, John Radcliffe Hospital, Level 5, Headley Way, Oxford, Oxfordshire, UK, OX3 9DU. bongani.mayosi@wolfson.oxford.ac.uk

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From the Editor's Desk.

Cardiovascular journal of Africa·2023
Same author

From the Editor's Desk.

Cardiovascular journal of Africa·2023
Same author

From the Editor's Desk.

Cardiovascular journal of Africa·2023
Same author

From the Editor's Desk.

Cardiovascular journal of Africa·2023
Same author

From the Editor's Desk.

Cardiovascular journal of Africa·2022
Same author

Covid-19 and cardiovascular disease.

Cardiovascular journal of Africa·2021

Adjuvant steroids may improve survival for tuberculous pericarditis, but more research is needed. Surgical drainage may prevent cardiac tamponade in TB pericarditis patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Clinical Trials

Background:

  • Tuberculous pericarditis (TB pericarditis) is an increasing concern.
  • This infection can lead to fatal fluid accumulation around the heart.

Purpose of the Study:

  • To assess evidence from clinical trials on medical and surgical treatments for TB pericarditis.
  • To evaluate the impact of these treatments on mortality and severe health conditions.

Main Methods:

  • Searched multiple databases including Cochrane, Medline, and Embase for relevant trials.
  • Included randomized and quasi-randomized trials evaluating treatments for TB pericarditis.
  • Conducted meta-analysis using fixed-effect models to calculate summary statistics.

Related Experiment Videos

Main Results:

  • Three trials with 411 participants examined adjuvant steroids and surgical drainage.
  • Steroid treatment showed a trend towards reduced all-cause mortality (RR 0.65) and improved cure rates in effusion cases (RR 0.69).
  • Surgical drainage did not affect mortality but significantly reduced cardiac tamponade risk (RR 0.04).

Conclusions:

  • Steroids show potential for significant survival benefits in TB pericarditis, though current trials are too small.
  • Further placebo-controlled trials are recommended to confirm steroid efficacy and explore influencing factors like effusion or fibrosis.
  • Additional research is necessary to fully evaluate the role of surgical interventions.